Jong Min Park1,2,3,4, Chang Heon Choi1,2,3, Hong-Gyun Wu1,2,3,4, Jung-In Kim1,2,3. 1. Department of Radiation Oncology, Seoul National University Hospital, Seoul, Korea. 2. Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Korea. 3. Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea. 4. Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea.
Abstract
PURPOSE: The aim of this study was to investigate the correlations of the gamma passing rates (GPR) with the dose-volumetric parameter changes between the original volumetric modulated arc therapy (VMAT) plans and the actual deliveries of the VMAT plans (DV errors). We compared the correlations of the TrueBeam STx system to those of a C-series linac. METHODS: A total of 20 patients with head and neck (H&N) cancer were retrospectively selected for this study. For each patient, two VMAT plans with the TrueBeam STx and Trilogy (C-series linac) systems were generated under similar modulation degrees. Both the global and local GPRs with various gamma criteria (3%/3 mm, 2%/2 mm, 2%/1 mm, 1%/2 mm, and 1%/1 mm) were acquired with the 2D dose distributions measured using the MapCHECK2 detector array. During VMAT deliveries, the linac log files of the multi-leaf collimator positions, gantry angles, and delivered monitor units were acquired. The DV errors were calculated with the 3D dose distributions reconstructed using the log files. Subsequently, Spearman's rank correlation coefficients (rs) and the corresponding p values were calculated between the GPRs and the DV errors. RESULTS: For the Trilogy system, the rs values with p < 0.05 showed weak correlations between the GPRs and the DV errors (rs<0.4) whereas for the TrueBeam STx system, moderate or strong correlations were observed (rs≥0.4). The DV errors in the V20Gy of the left parotid gland and those in the mean dose of the right parotid gland showed strong correlations (always with rs > 0.6) with the GPRs with gamma criteria except 3%/3 mm. As the GPRs increased, the DV errors decreased. CONCLUSION: The GPRs showed strong correlations with some of the DV errors for the VMAT plans for H&N cancer with the TrueBeam STx system.
PURPOSE: The aim of this study was to investigate the correlations of the gamma passing rates (GPR) with the dose-volumetric parameter changes between the original volumetric modulated arc therapy (VMAT) plans and the actual deliveries of the VMAT plans (DV errors). We compared the correlations of the TrueBeam STx system to those of a C-series linac. METHODS: A total of 20 patients with head and neck (H&N) cancer were retrospectively selected for this study. For each patient, two VMAT plans with the TrueBeam STx and Trilogy (C-series linac) systems were generated under similar modulation degrees. Both the global and local GPRs with various gamma criteria (3%/3 mm, 2%/2 mm, 2%/1 mm, 1%/2 mm, and 1%/1 mm) were acquired with the 2D dose distributions measured using the MapCHECK2 detector array. During VMAT deliveries, the linac log files of the multi-leaf collimator positions, gantry angles, and delivered monitor units were acquired. The DV errors were calculated with the 3D dose distributions reconstructed using the log files. Subsequently, Spearman's rank correlation coefficients (rs) and the corresponding p values were calculated between the GPRs and the DV errors. RESULTS: For the Trilogy system, the rs values with p < 0.05 showed weak correlations between the GPRs and the DV errors (rs<0.4) whereas for the TrueBeam STx system, moderate or strong correlations were observed (rs≥0.4). The DV errors in the V20Gy of the left parotid gland and those in the mean dose of the right parotid gland showed strong correlations (always with rs > 0.6) with the GPRs with gamma criteria except 3%/3 mm. As the GPRs increased, the DV errors decreased. CONCLUSION: The GPRs showed strong correlations with some of the DV errors for the VMAT plans for H&N cancer with the TrueBeam STx system.
Authors: Søren M Bentzen; Louis S Constine; Joseph O Deasy; Avi Eisbruch; Andrew Jackson; Lawrence B Marks; Randall K Ten Haken; Ellen D Yorke Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Tony Teke; Alanah M Bergman; William Kwa; Bradford Gill; Cheryl Duzenli; I Antoniu Popescu Journal: Med Phys Date: 2010-01 Impact factor: 4.071
Authors: Gary A Ezzell; Jay W Burmeister; Nesrin Dogan; Thomas J LoSasso; James G Mechalakos; Dimitris Mihailidis; Andrea Molineu; Jatinder R Palta; Chester R Ramsey; Bill J Salter; Jie Shi; Ping Xia; Ning J Yue; Ying Xiao Journal: Med Phys Date: 2009-11 Impact factor: 4.071
Authors: Moyed Miften; Arthur Olch; Dimitris Mihailidis; Jean Moran; Todd Pawlicki; Andrea Molineu; Harold Li; Krishni Wijesooriya; Jie Shi; Ping Xia; Nikos Papanikolaou; Daniel A Low Journal: Med Phys Date: 2018-03-23 Impact factor: 4.071